Rising Chronic Disease Prevalence Driving Growth In Immunofluorescence Assay Market: Powering Innovation and Expansion in the Immunofluorescence Assay Market by 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Immunofluorescence Assay Market Through 2025?
In recent times, we've witnessed the substantial growth of the immunofluorescence assay market. The market, worth $3.34 billion in 2024, is projected to reach a value of $3.59 billion in 2025, which equates to a compound annual growth rate (CAGR) of 7.4%. The upward trend observed during the historical period is primarily due to factors such as the escalation in disease diagnosis, greater emphasis on research and development, the increasing prevalence of autoimmune diseases, improved cancer diagnostics, and a surge in virology research.

What's the Projected Size of the Global Immunofluorescence Assay Market by 2029?
The market size of the immunofluorescence assay is predicted to experience swift expansion in the upcoming years, with an estimated value of $5.4 billion by 2029 and a compound annual growth rate (CAGR) of 10.7%. The surge during the prediction period is credited to the rise in personalized medicine, increasing surveillance of infectious diseases, escalation in autoimmune disorders, growth in point-of-care testing, and amplified global health readiness. Key emerging trends during this projected period include the use of multiplex assays, advancement in automation and robotics, the incorporation of high-content imaging, development of advanced fluorophores, and the inclusion of digital pathology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Top Growth Drivers in the Immunofluorescence Assay Industry: What's Accelerating the Market?
The immunofluorescence assay market's growth rate is being heavily propelled by the escalating frequency of chronic illnesses. Factors such as lifestyle changes, diet tendencies, and improper weight control are linked to the exponential surge in persistent diseases, with cancer risk being spawned from ongoing chronic infections. The escalating frequency of chronic illnesses is probable to stimulate the demand for immunofluorescence assays, as they are crucial for diagnosis and drug research activities. For example, data released by the Centers for Disease Control and Prevention demonstrates that nearly 6 out of 10 American adults suffer from chronic diseases, resulting in an approximated annual healthcare expenditure of $3.8 trillion. Thus, the growing rate of chronic diseases is likely to stimulate the need for immunofluorescence assays over the predicted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

What Trends Will Shape the Immunofluorescence Assay Market Through 2029 and Beyond?
Technological advancements are becoming increasingly popular within the immunofluorescence assay market, as a notable trend. To meet specific technical requirements for identification of new viruses like COVID-19, and to fortify their market standing, companies in the immunofluorescence assay sphere are focusing on creating technologically innovative products. An example would be LumiraDx, a developer of point-of-care diagnostics from UK who in March 2022, received emergency clearance for their LumiraDx SARS-CoV-2 Ag Test. This is a microfluidic immunofluorescence assay geared towards the qualitative detection of nucleocapsid protein antigen from nasal swab specimens.

What Are the Main Segments in the Immunofluorescence Assay Market?
The immunofluorescence assay market covered in this report is segmented -

1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Hospitals And Diagnostic Centers

Subsegments:
1) By Direct Immunofluorescence: Single-Step Direct Assays, Multiplex Direct Assays
2) By Indirect Immunofluorescence: Single-Step Indirect Assays, Multiplex Indirect Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6778&type=smp

Which Top Companies are Driving Growth in the Immunofluorescence Assay Market?
Major companies operating in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH

Which Regions Will Dominate the Immunofluorescence Assay Market Through 2029?
North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6778

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.